Report Detail
Global (United States, European Union and China) Autologous Matrix-induced Chondrogenesis Market Research Report 2019-2025
- RnM3665606 |
- 13 August, 2019 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
utologous matrix-induced chondrogenesis (AMIC) is a 1-step cartilage restoration technique that combines microfracture with the use of an exogenous scaffold.
The functional principle of microfracturing is based on the release of multipotent mesenchymal progenitor cells, cytokines and growth factors from the subchondral bone.
In 2019, the market size of Autologous Matrix-induced Chondrogenesis is 100 million US$ and it will reach 180 million US$ in 2025, growing at a CAGR of 7.6% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Autologous Matrix-induced Chondrogenesis.
This report studies the global market size of Autologous Matrix-induced Chondrogenesis, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Autologous Matrix-induced Chondrogenesis sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
JRI Orthopaedics Ltd
BioTissue
Anika Therapeutics
B. Braun Melsungen
Arthro-Kinetics
Geistlich Pharma
CartiHeal
Matricel
Smith & Nephew
Zimmer Biomet Holdings
Market Segment by Product Type
Hyaluronic Acid
Collagen
Polyethylene Glycol (PEG)
Poly Lactic-Co-Glycolic Acid (PGLA)
Market Segment by Application
Knees Joint
Other
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Autologous Matrix-induced Chondrogenesis status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Autologous Matrix-induced Chondrogenesis manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Autologous Matrix-induced Chondrogenesis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Autologous Matrix-induced Chondrogenesis Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Hyaluronic Acid
- 1.3.3 Collagen
- 1.3.4 Polyethylene Glycol (PEG)
- 1.3.5 Poly Lactic-Co-Glycolic Acid (PGLA)
- 1.4 Market Segment by Application
- 1.4.1 Global Autologous Matrix-induced Chondrogenesis Market Share by Application (2019-2025)
- 1.4.2 Knees Joint
- 1.4.3 Other
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Autologous Matrix-induced Chondrogenesis Market Size
- 2.1.1 Global Autologous Matrix-induced Chondrogenesis Revenue 2014-2025
- 2.1.2 Global Autologous Matrix-induced Chondrogenesis Sales 2014-2025
- 2.2 Autologous Matrix-induced Chondrogenesis Growth Rate by Regions
- 2.2.1 Global Autologous Matrix-induced Chondrogenesis Sales by Regions 2014-2019
- 2.2.2 Global Autologous Matrix-induced Chondrogenesis Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Autologous Matrix-induced Chondrogenesis Sales by Manufacturers
- 3.1.1 Autologous Matrix-induced Chondrogenesis Sales by Manufacturers 2014-2019
- 3.1.2 Autologous Matrix-induced Chondrogenesis Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Autologous Matrix-induced Chondrogenesis Revenue by Manufacturers (2014-2019)
- 3.2.2 Autologous Matrix-induced Chondrogenesis Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Autologous Matrix-induced Chondrogenesis Market Concentration Ratio (CR5 and HHI)
- 3.3 Autologous Matrix-induced Chondrogenesis Price by Manufacturers
- 3.4 Key Manufacturers Autologous Matrix-induced Chondrogenesis Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Autologous Matrix-induced Chondrogenesis Market
- 3.6 Key Manufacturers Autologous Matrix-induced Chondrogenesis Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Hyaluronic Acid Sales and Revenue (2014-2019)
- 4.1.2 Collagen Sales and Revenue (2014-2019)
- 4.1.3 Polyethylene Glycol (PEG) Sales and Revenue (2014-2019)
- 4.1.4 Poly Lactic-Co-Glycolic Acid (PGLA) Sales and Revenue (2014-2019)
- 4.2 Global Autologous Matrix-induced Chondrogenesis Sales Market Share by Type
- 4.3 Global Autologous Matrix-induced Chondrogenesis Revenue Market Share by Type
- 4.4 Autologous Matrix-induced Chondrogenesis Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Autologous Matrix-induced Chondrogenesis Sales by Application
6 United States
- 6.1 United States Autologous Matrix-induced Chondrogenesis Breakdown Data by Company
- 6.2 United States Autologous Matrix-induced Chondrogenesis Breakdown Data by Type
- 6.3 United States Autologous Matrix-induced Chondrogenesis Breakdown Data by Application
7 European Union
- 7.1 European Union Autologous Matrix-induced Chondrogenesis Breakdown Data by Company
- 7.2 European Union Autologous Matrix-induced Chondrogenesis Breakdown Data by Type
- 7.3 European Union Autologous Matrix-induced Chondrogenesis Breakdown Data by Application
8 China
- 8.1 China Autologous Matrix-induced Chondrogenesis Breakdown Data by Company
- 8.2 China Autologous Matrix-induced Chondrogenesis Breakdown Data by Type
- 8.3 China Autologous Matrix-induced Chondrogenesis Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Autologous Matrix-induced Chondrogenesis Breakdown Data by Company
- 9.2 Rest of World Autologous Matrix-induced Chondrogenesis Breakdown Data by Type
- 9.3 Rest of World Autologous Matrix-induced Chondrogenesis Breakdown Data by Application
- 9.4 Rest of World Autologous Matrix-induced Chondrogenesis Breakdown Data by Countries
- 9.4.1 Rest of World Autologous Matrix-induced Chondrogenesis Sales by Countries
- 9.4.2 Rest of World Autologous Matrix-induced Chondrogenesis Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 JRI Orthopaedics Ltd
- 10.1.1 JRI Orthopaedics Ltd Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Autologous Matrix-induced Chondrogenesis
- 10.1.4 Autologous Matrix-induced Chondrogenesis Product Introduction
- 10.1.5 JRI Orthopaedics Ltd Recent Development
- 10.2 BioTissue
- 10.2.1 BioTissue Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Autologous Matrix-induced Chondrogenesis
- 10.2.4 Autologous Matrix-induced Chondrogenesis Product Introduction
- 10.2.5 BioTissue Recent Development
- 10.3 Anika Therapeutics
- 10.3.1 Anika Therapeutics Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Autologous Matrix-induced Chondrogenesis
- 10.3.4 Autologous Matrix-induced Chondrogenesis Product Introduction
- 10.3.5 Anika Therapeutics Recent Development
- 10.4 B. Braun Melsungen
- 10.4.1 B. Braun Melsungen Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Autologous Matrix-induced Chondrogenesis
- 10.4.4 Autologous Matrix-induced Chondrogenesis Product Introduction
- 10.4.5 B. Braun Melsungen Recent Development
- 10.5 Arthro-Kinetics
- 10.5.1 Arthro-Kinetics Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Autologous Matrix-induced Chondrogenesis
- 10.5.4 Autologous Matrix-induced Chondrogenesis Product Introduction
- 10.5.5 Arthro-Kinetics Recent Development
- 10.6 Geistlich Pharma
- 10.6.1 Geistlich Pharma Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Autologous Matrix-induced Chondrogenesis
- 10.6.4 Autologous Matrix-induced Chondrogenesis Product Introduction
- 10.6.5 Geistlich Pharma Recent Development
- 10.7 CartiHeal
- 10.7.1 CartiHeal Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Autologous Matrix-induced Chondrogenesis
- 10.7.4 Autologous Matrix-induced Chondrogenesis Product Introduction
- 10.7.5 CartiHeal Recent Development
- 10.8 Matricel
- 10.8.1 Matricel Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Autologous Matrix-induced Chondrogenesis
- 10.8.4 Autologous Matrix-induced Chondrogenesis Product Introduction
- 10.8.5 Matricel Recent Development
- 10.9 Smith & Nephew
- 10.9.1 Smith & Nephew Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Autologous Matrix-induced Chondrogenesis
- 10.9.4 Autologous Matrix-induced Chondrogenesis Product Introduction
- 10.9.5 Smith & Nephew Recent Development
- 10.10 Zimmer Biomet Holdings
- 10.10.1 Zimmer Biomet Holdings Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Autologous Matrix-induced Chondrogenesis
- 10.10.4 Autologous Matrix-induced Chondrogenesis Product Introduction
- 10.10.5 Zimmer Biomet Holdings Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Autologous Matrix-induced Chondrogenesis Sales Channels
- 11.2.2 Autologous Matrix-induced Chondrogenesis Distributors
- 11.3 Autologous Matrix-induced Chondrogenesis Customers
12 Market Forecast
- 12.1 Global Autologous Matrix-induced Chondrogenesis Sales and Revenue Forecast 2019-2025
- 12.2 Global Autologous Matrix-induced Chondrogenesis Sales Forecast by Type
- 12.3 Global Autologous Matrix-induced Chondrogenesis Sales Forecast by Application
- 12.4 Autologous Matrix-induced Chondrogenesis Forecast by Regions
- 12.4.1 Global Autologous Matrix-induced Chondrogenesis Sales Forecast by Regions 2019-2025
- 12.4.2 Global Autologous Matrix-induced Chondrogenesis Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on AutologousMatrix-inducedChondrogenesis. Industry analysis & Market Report on AutologousMatrix-inducedChondrogenesis is a syndicated market report, published as Global (United States, European Union and China) Autologous Matrix-induced Chondrogenesis Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of AutologousMatrix-inducedChondrogenesis market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
